Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetes.

A D Timmis1

  • 1Department of Cardiology, London Chest Hospital, London, UK.

British Medical Bulletin
|January 5, 2002
PubMed
Summary

Diabetes significantly increases cardiovascular risk and mortality. Recent trials highlight blood pressure control, ACE inhibitors, and insulin therapy as key strategies to reduce this risk in diabetic patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Geographic variation in the treatment of non-ST-segment myocardial infarction in the English National Health Service: a cohort study.

BMJ open·2016
Same author

Long-term excess mortality associated with diabetes following acute myocardial infarction: a population-based cohort study.

Journal of epidemiology and community health·2016
Same author

Importance of primary percutaneous coronary intervention for reducing mortality in ST-elevation myocardial infarction complicated by out of hospital cardiac arrest.

European heart journal. Acute cardiovascular care·2014
Same author

Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention.

Heart (British Cardiac Society)·2011
Same author

National society cardiovascular journals of Europe: Almanac 2011.

Heart (British Cardiac Society)·2011
Same author

Incidence and prognosis of angina pectoris in South Asians and Whites: 18 years of follow-up over seven phases in the Whitehall-II prospective cohort study.

Journal of public health (Oxford, England)·2010

Area of Science:

  • Cardiology
  • Diabetology
  • Endocrinology

Background:

  • Diabetes profoundly increases cardiovascular morbidity and mortality.
  • Autonomic neuropathy in diabetes can mask or alter cardiac pain perception, delaying critical treatment.
  • Accelerated atherogenesis in diabetes remains a significant clinical challenge.

Purpose of the Study:

  • To review the cardiovascular complications of diabetes.
  • To highlight recent therapeutic advances in managing cardiovascular risk in diabetic patients.
  • To emphasize the importance of risk factor modification and novel treatment strategies.

Main Methods:

  • Review of landmark clinical trials including UKPDS, HOPE, and DIGAMI.
  • Analysis of evidence-based cardiovascular risk reduction strategies in diabetes.
  • Examination of the impact of autonomic neuropathy on cardiac symptom presentation.

Main Results:

  • Recent trials identified blood pressure control and converting enzyme inhibition as crucial for reducing cardiovascular risk in diabetes.
  • Insulin therapy demonstrated value in reducing mortality in diabetic myocardial infarction.
  • Established risk factor modification, while important, may not offer additional protection beyond that in non-diabetics.

Conclusions:

  • Novel strategies, particularly blood pressure management and ACE inhibitors, are vital for cardiovascular risk reduction in diabetes.
  • Insulin therapy is a key intervention for diabetic myocardial infarction mortality.
  • Ongoing research is essential to further refine cardiovascular management for the growing diabetic population.

Related Experiment Videos